Hi Modest,
Could you send me the exact connection string that you are using please?
I want to double check it from here
a
On 16/12/10 4:27 AM, "modest.ko...@actelion.com" <modest.ko...@actelion.com>
wrote:
To whom it may concern
it seems that your CVS server is down. I tried to get the Java sources and
docs, but I got a connection error.
Best regards,
Modest
Modest von Korff (PhD, Pharmacist)
Senior Research Informatician
Actelion Pharmaceuticals Ltd / Gewerbestrasse 16 / CH - 4123 Allschwil /
Switzerland /
phone +41 61 565 6323 / fax +41 61 487 45 00 / modest.ko...@actelion.com /
www.actelion.com <www.actelion.com>
From: majord...@ebi.ac.uk
To: modest.ko...@actelion.com
Date: 16.12.2010 10:13
Subject: Welcome to mart-dev
________________________________
--
Welcome to the mart-dev mailing list!
Please save this message for future reference. Thank you.
If you ever want to remove yourself from this mailing list,
you can send mail to <majord...@ebi.ac.uk> with the following
command in the body of your email message:
unsubscribe mart-dev
or from another account, besides modest.ko...@actelion.com:
unsubscribe mart-dev modest.ko...@actelion.com
If you ever need to get in contact with the owner of the list,
(if you have trouble unsubscribing, or have questions about the
list itself) send email to <owner-mart-...@ebi.ac.uk> .
This is the general rule for most mailing lists when you need
to contact a human.
Here's the general information for the list you've subscribed to,
in case you don't already have it:
The information of this email and in any file transmitted with it is strictly
confidential and may be legally privileged.
It is intended solely for the addressee. If you are not the intended recipient,
any copying, distribution or any other use of this email is prohibited and may
be unlawful. In such case, you should please notify the sender immediately and
destroy this email.
The content of this email is not legally binding unless confirmed by letter.
Any views expressed in this message are those of the individual sender, except
where the message states otherwise and the sender is authorised to state them
to be the views of the sender's company. For further information about Actelion
please see our website at http://www.actelion.com
Arek Kasprzyk
Director, Bioinformatics Operations and Principal Investigator
Ontario Institute for Cancer Research
MaRS Centre, South Tower
101 College Street, Suite 800
Toronto, Ontario, Canada M5G 0A3
Tel: 416-673-8559
Toll-free: 1-866-678-6427
www.oicr.on.ca
This message and any attachments may contain confidential and/or privileged
information for the sole use of the intended recipient. Any review or
distribution by anyone other than the person for whom it was originally
intended is strictly prohibited. If you have received this message in error,
please contact the sender and delete all copies. Opinions, conclusions or other
information contained in this message may not be that of the organization.
